Solu-medrol and Diffuse interstitial lung disease - a phase IV clinical study of FDA data

Summary:

Diffuse interstitial lung disease is reported as a side effect among people who take Solu-medrol (methylprednisolone sodium succinate), especially for people who are female, 40-49 old, have been taking the drug for < 1 month also take Nexium, and have Tracheitis.

The phase IV clinical study analyzes which people have Diffuse interstitial lung disease when taking Solu-medrol. It is created by eHealthMe based on reports of 39,265 people who have side effects when taking Solu-medrol from the FDA, and is updated regularly.

What is Solu-medrol?

Solu-medrol has active ingredients of methylprednisolone sodium succinate. It is often used in multiple sclerosis. eHealthMe is studying from 39,410 Solu-medrol users. Check the latest studies of Solu-medrol.

What is Diffuse interstitial lung disease?

Diffuse interstitial lung disease (group of lung diseases affecting the interstitium) is found to be associated with 230 drugs and 799 conditions by eHealthMe. Check the latest studies of Diffuse interstitial lung disease.

On Jul, 07, 2026

39,265 people reported to have side effects when taking Solu-medrol.
Among them, 16 people (0.04%) have Diffuse interstitial lung disease.

Could Solu-medrol cause Diffuse interstitial lung disease?

Among these 16 people:

How long have people been on Solu-medrol when they have Diffuse interstitial lung disease? *

What is the gender of people who have Diffuse interstitial lung disease when taking Solu-medrol? *

female: 85.71 %
male: 14.29 %

What is the age of people who have Diffuse interstitial lung disease when taking Solu-medrol? *

What are other drugs people take besides Solu-medrol? *

What are other side effects people have besides Diffuse interstitial lung disease? *

Fever: 9 people, 56.25%
Dyspnea (difficult or laboured breathing): 7 people, 43.75%
Pleural Effusion (water on the lungs): 6 people, 37.50%
Lung Disorder (lung disease): 6 people, 37.50%
Portal Hypertension (increase in the blood pressure within a system of veins called the portal venous system): 5 people, 31.25%
Peritoneal Effusion (fluid in the peritoneal): 5 people, 31.25%
Hepatocellular Damage (liver damage): 5 people, 31.25%
Hepatitis Cholestatic (flow of bile from the liver is slowed or blocked): 5 people, 31.25%
Weight Decreased: 5 people, 31.25%
Jaundice - Yellow Skin (a yellowish pigmentation of the skin): 5 people, 31.25%

What are the existing conditions these people have? *

Tracheitis (an inflammation of the trachea): 5 people, 31.25%
Pain: 4 people, 25.00%
Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 3 people, 18.75%
Lung Disorder (lung disease): 2 people, 12.50%
Superinfection Lung: 1 person, 6.25%
Ovarian Cancer Recurrent (reoccurrence of ovary cancer): 1 person, 6.25%
Ovarian Cancer (cancer of ovary): 1 person, 6.25%
Neuralgia (pain in one or more nerves): 1 person, 6.25%
Neoplasm Malignant (cancer tumour): 1 person, 6.25%
Nausea And Vomiting: 1 person, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Solu-medrol and have Diffuse interstitial lung disease?

- Check whether Diffuse interstitial lung disease is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Solu-medrol:

Solu-medrol (39,410 reports)

Diffuse interstitial lung disease treatments and more:

Diffuse interstitial lung disease (2,067 reports)

How severe was Diffuse interstitial lung disease and when was it recovered:

Diffuse interstitial lung disease in Solu-medrol

Expand to all the drugs that have ingredients of methylprednisolone sodium succinate:

Diffuse interstitial lung disease and drugs with ingredients of methylprednisolone sodium succinate (131 reports)

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Solu-medrol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Diffuse interstitial lung disease:

Diffuse interstitial lung disease (230 drugs)

Browse all the conditions that are associated with Diffuse interstitial lung disease:

Diffuse interstitial lung disease (799 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on methylprednisolone sodium succinate (the active ingredients of Solu-medrol) and Solu-medrol (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.